Bartholomew Advisors is focused on executive search within Life Sciences for clients ranging from small private equity backed companies to the largest corporations in the world. We exclusively work on roles of critical importance to our clients. Typically, such roles include Chair, independent board directors, CEOs and heads of a function that report to a CEO, however any role that is mission critical for our clients would be undertaken. We advise public companies and, occasionally, charitable organizations.
Clients are based in the US and across Europe. A considerable number of our searches are North American in focus, many are pan-European and the rest, global. We are experts at advising on the challenges of international relocations.
For existing clients, we carry out market mapping projects to determine if an executive search is worthwhile. Our advice is impartial and expert.
As a boutique consultancy, we are less encumbered by the off-limit restrictions larger agencies operate under, so can focus on delivering you the perfect candidate for your position.
About HSBC Innovation Banking
We are specialists in the innovation economy, helping visionaries with entrepreneurial minds achieve their ambitions and beyond. We support clients and investors through all business life stages, from pre-Series A to post IPO, with our deep sector expertise, stability, and international reach. We work with the most innovative, venture-backed businesses and their investors across all life stages, within the technology, life sciences, and healthcare sectors. Visit us at: http://innovationbanking.hsbc
HSBC Holdings plc, the parent company of HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 60 countries and territories. With assets of US$2,975bn at 30 June 2024, HSBC is one of the world’s largest banking and financial services organizations.
HSBC Bank USA, National Association (HSBC Bank USA, N.A.) serves customers through Wealth and Personal Banking, Commercial Banking, Private Banking, Global Banking, and Markets and Securities Services. Deposit products are offered by HSBC Bank USA, N.A., Member FDIC. It operates Wealth Centers in: California; Washington, D.C.; Florida; New Jersey; New York; Virginia; and Washington. HSBC Bank USA, N.A. is the principal subsidiary of HSBC USA Inc., a wholly-owned subsidiary of HSBC North America Holdings Inc.
We bring together the brightest minds in New England’s vibrant life sciences sectors, including biotechnology, pharmaceuticals, artificial intelligence, healthcare venture capital, data analytics, and precision medicine. Whether you’re looking to forge strategic partnerships, stay ahead of industry trends, or explore new markets, NEBCO is here to facilitate your growth. Our platform also connects startups and established businesses with venture capitalists and investors ready to support innovations across the bioscience and healthcare landscape.
We produce the NEBCO Leadership Conference, taking place on April 23-24, 2025, in New Haven, CT. This event serves as a convergence point for academia, industry leaders, healthcare providers, and investors, driving groundbreaking research and development while providing insight to New England’s flourishing bioscience industry. NEBCO is essential for companies looking to collaborate with New England’s bioscience and life science organizations. Our region is renowned for its synergistic environment that cultivates robust connections among academia, industry, and healthcare providers, establishing it as a hub for biomedical research and innovation. Attending the conference offers invaluable networking opportunities with key players and insights into the latest advancements in bioscience. This makes it a must-attend event for anyone eager to engage with and benefit from New England’s dynamic bioscience community.
Join us at NEBCO 2025 and be part of a community dedicated to shaping the future of healthcare and bioscience innovation! www.nebco.org
The Associated Construction Company was incorporated in New London, CT on August 4, 1942 by Angelo Giardini. The organization was originally founded as a military defense contractor and constructed various base facilities for the US Navy and its submarine base in Groton. With a growing need for housing, Associated Construction increasingly expanded into multi-residential construction. In 1946, Associated Construction relocated to Hartford, CT to broaden its client base, and its reputation for quality construction work in the areas of housing development, commercial offices, retail facilities, industrial plants, healthcare facilities, industrial structures and water sewage treatment plants quickly grew. Today, the firm is led by President Joseph Jankowski, and Vice President Kevin McConnell. Joe’s introduction to the industry began with the Associated Construction Company in 1984, and Kevin’s in 2021. Both leaders have been exposed to complex technical projects which have imparted a high level of skill, experience and management techniques. The diversity of positions held between them include field engineer, project engineer, superintendent, estimator, project manager and project executive, which enables them to continue to expand Associated Construction’s legacy of excellence.
The Associated Construction Company excels in constructing bio-technical, pharmacological, and pharmaceutical facilities. We prioritize collaboration with the entire project team from the onset of design development through to the commissioning of the facility. From the beginning, we engage with the owner and design team to evaluate the overall project, considering its impact on surrounding areas, the importance of maintaining ongoing operations, and best practices for ensuring the highest quality construction. Safety is at the forefront of our planning and execution, ensuring that all protocols are strictly followed to protect everyone involved.
We then develop an action plan that integrates project-specific logistics with design requirements, always keeping safety as a top priority. We employ various procurement strategies to mitigate potential risks associated with different design and construction methodologies. We select subcontractor trade partners with a proven track record in complex projects and familiarity with sophisticated engineering systems to ensure successful and safe project completion.
Forvis Mazars, LLP is an independent member of Forvis Mazars Global, a leading global professional services network. Ranked among the largest public accounting firms in the United States, the firm’s 7,000 dedicated team members provide an Unmatched Client Experience® through the delivery of assurance, tax, and consulting services for clients in all 50 states and internationally through the global network.
Spatial biology research tools company.
Research Activities:
Wet lab assay development and dry lab engineering.
At Safety Partners, we redefine environmental health and safety (EHS) in the workplace and labs with innovative solutions tailored to your needs. Over 32 years in serving the life sciences, biotech, real estate, and light manufacturing industries, we continue to empower organizations to proactively manage risks and cultivate a culture of safety. From initial permitting to job safety analyses, to emergency response planning and safety training – our team of experts are fully dedicated to fostering secure work environments. Join us in revolutionizing safety management and protecting your most valuable assets – because your peace of mind is our priority.
BiologicsMD is a private drug discovery and development company that focuses on novel and highly targeted agonists and antagonists to the PTH/PTHrP receptor for advanced treatments in hair loss conditions, bone disorders and prevention of bone metastases. We are funded through Connecticut Innovations and private investors and are seeking our first institutional raise to complete our first in-human clinical trials that we believe could lead to an early exit. We have formed a close relationship with thought-leading physicians in alopecia from Yale University and other centers of excellence. Our lead program, BMD-1141 has been shown to reverse hair loss quickly in animal models of chemotherapy-induced alopecia and alopecia areata. Currently no reliable animal model of androgenetic alopecia (male pattern baldness) is available, but the mechanism by which BMD-1141 works clearly matches the mechanism that could reverse this common form of alopecia. Alhough a small company today, BiologicsMD is committed to building its presence in the State of Connecticut and contributing to the already robust biopharmaceutical ecosystem.
Research Activities:
BiologicsMD’s lead asset, BMD-1141, is a patent-protected, first-in-class hair cycle stimulator for the treatment of various types of non-scarring alopecia including alopecia areata, chemotherapy-induced alopecia, and androgenetic alopecia. BMD-1141 has a novel mechanism of action and is expected to promote hair growth more effectively, with subcutaneous dosing every 1-6 months, without the serious side effects of existing treatments.The pre-clinical data package for the treatment of alopecia includes multiple animal models, providing clear evidence of efficacy and safety. Importantly, the safety profile generated from in vitro and in vivo studies of BMD-1141 demonstrate no siginfiant risk factors. Related to the mechanism of action, BMD-1141, even at 10x the maximally efficacious dose, does not result in hypercalcemia. The manufacturing platform data includes formulations and long-term stability. BiologicsMD is currently in the process of raising their first institutional round of $17MM to fund a phase IA clinical trial in a population enriched with androgenetic alopecia subjects, and a phase IB clinical trial in alopecia areata patients. Upcoming research activities include clinical batch manufacturing and IND-enabling toxicology. Completion of these steps and the phase IA clinical trial is expected to take 27 months.
JK Creative is a CT-based video production and strategic consulting company founded by Jesse Krinsky. Jesse has over 20 years of experience producing video content in the life science industry, including managing video production and creative strategy for Thermo Fisher Scientific. Previous clients include GlaxoSmithKline, Amgen, Johnson & Johnson, Qiagen, Philips Healthcare, Specialists on Call, and more.
In addition to video production, JK Creative specializes in strategic consulting services:
The American Cancer Society Cancer Action Network (ACS CAN) advocates for evidence-based public policies to reduce the cancer burden for everyone. We engage our volunteers across the country to make their voices heard by policymakers at every level of government. We believe everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer.
Since 2001, as the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures.
We stand with our volunteers—people whose lives have been impacted by cancer—rallying to demand change. Together, we’re working to make cancer a top priority for public officials and candidates at the federal, state, and local levels. By engaging advocates across the country to make their voices heard, ACS CAN influences legislative and regulatory solutions that will end cancer as we know it, for everyone.
Research Activities:
No single nongovernmental, not-for-profit organization in the US has invested more to find the causes and cures of cancer than the American Cancer Society (ACS). In fact, we’ve helped make possible almost every major cancer research breakthrough since 1946.
ACS CAN supports state initiatives that appropriate funding to support scientific research on cutting-edge treatments, cancer prevention and early detection and ways to reduce cancer disparities. ACS CAN will look for opportunities to increase appropriation dollars for biomedical research.
The American Cancer Society Cancer Action Network (ACS CAN) advocates for evidence-based public policies to reduce the cancer burden for everyone. We engage our volunteers across the country to make their voices heard by policymakers at every level of government. We believe everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer.
Since 2001, as the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures.
We stand with our volunteers—people whose lives have been impacted by cancer—rallying to demand change. Together, we’re working to make cancer a top priority for public officials and candidates at the federal, state, and local levels. By engaging advocates across the country to make their voices heard, ACS CAN influences legislative and regulatory solutions that will end cancer as we know it, for everyone.
Research Activities:
No single nongovernmental, not-for-profit organization in the US has invested more to find the causes and cures of cancer than the American Cancer Society (ACS). In fact, we’ve helped make possible almost every major cancer research breakthrough since 1946.
ACS CAN supports state initiatives that appropriate funding to support scientific research on cutting-edge treatments, cancer prevention and early detection and ways to reduce cancer disparities. ACS CAN will look for opportunities to increase appropriation dollars for biomedical research.